The macroautophagy machinery has been implicated in MHC class II restricted antigen presentation. Here, we report that this machinery assists in the internalization of MHC class I molecules. In the absence of the autophagy factors Atg5 and Atg7, MHC class I surface levels are elevated due to decreased endocytosis and degradation. Internalization of MHC class I molecules occurs less efficiently if AAK1 cannot be recruited via Atg8/LC3B. In the absence of Atg-dependent MHC class I internalization, dendritic cells stimulate CD8 + T cell responses more efficiently in vitro and in vivo. During viral infections, lack of Atg5 results in enhanced influenzaand LCMV-specific CD8 + T cell responses in vivo. Elevated influenza-specific CD8 + T cell responses are associated with better immune control of this infection. Thus, the macroautophagy machinery orchestrates T cell immunity by supporting MHC class II but compromises MHC class I restricted antigen presentation.
In Brief
Macroautophagy assists in antigen processing for MHC class II presentation. In contrast to this supportive role for CD4 + T cell stimulation, Loi et al.
demonstrate that macroautophagy proteins diminish antigen presentation on MHC class I molecules during anti-viral CD8 + T cell responses by supporting MHC class I internalization in dendritic cells.
INTRODUCTION
Macroautophagy is a major bulk degradative pathway in the cell, acting in parallel to the proteasome to degrade intracellular proteins and cell organelles (Mizushima et al., 2011) . More than 30 autophagy related gene (atg) products form a double-membrane vesicle that engulfs cytoplasmic constituents bound to Atg8, an autophagy-related ubiquitin-like molecule that gets coupled to autophagosomal membranes. Yeast Atg8 has at least seven orthologs in higher eukaryotic cells, namely LC3A-C, GABARAP, and GABARAPL1-3. Initially thought to be a non-selective intracellular pathway of bulk degradation, there is now growing evidence that defines autophagy as a fine-tuned process with high cargo selectivity. Indeed, autophagy receptors, such as p62/sequestosome 1, optineurin, NBR-1, and NDP52, bind to substrates and recruit them to autophagosomal membranes, through binding of their LC3-interacting regions (LIRs) to Atg8 (Stolz et al., 2014) . Autophagy substrates may comprise ubiquitinated proteins, N-terminally arginylated proteins, proteins with exposed glycosylation, and even organelles (Cha-Molstad et al., 2015; Randow and M€ unz, 2012) . Macroautophagy is constitutively active in leukocytes and can mediate both adaptive and innate immune responses. During the innate immune response, various Toll-and NOD-like receptors (TLRs and NLRs) can enhance macroautophagy (Cooney et al., 2010; Delgado et al., 2009) . The pathway also directly degrades intracellular pathogens, and some bacteria and viruses have evolved to develop strategies to escape autophagic degradation (Choi et al., 2013) . During the adaptive immune response, macroautophagy in antigen-presenting cells has been shown to directly control CD4 + T cell responses, by regulating the delivery of both endogenous proteins and exogenous phagocytosed antigens to major histocompatibility complex (MHC) class II loading compartments (Lee et al., 2010; . Endogenous self-protein processing via macroautophagy contributes to both positive and negative CD4 + T cell selection via presentation on MHC class II molecules in the thymus (Aichinger et al., 2013; Nedjic et al., 2008) . This involves canonical macroautophagy and can be increased by selective targeting to autophagosomes via antigen fusion to LC3B. In contrast, exogenous antigen processing for MHC class II presentation seems to utilize the macroautophagy machinery via LC3-associated phagocytosis (LAP) (Ma et al., 2012; Romao et al., 2013) . In this pathway, LC3B is coupled to the cytosolic side of phagosomal membranes around cargo that has stimulated the recruitment of NADPH oxidase (NOX2) to the phagosomal membrane (Martinez et al., 2015; Romao et al., 2013) . Reactive oxygen species production by NOX2 is required for LC3B recruitment to phagosomes, which, depending on the cell type, seems to accelerate or attenuate fusion with lysosomes. In the case of attenuation of lysosome fusion, MHC class II presentation of the endocytosed antigens seems to be prolonged (Romao et al., 2013) . Compared to antigen processing for MHC class II presentation, little is known about the mechanisms by which the macroautophagy machinery influences MHC class I restricted antigen presentation. Here, we report that antigen-presenting cells, like dendritic cells (DCs), which lack the core macroautophagy machinery that mediates Atg8 lipidation, have elevated surface MHC class I expression. This results from attenuated internalization and degradation of MHC class I molecules, and it involves the adaptor-associated kinase 1 (AAK1), which is recruited to MHC class I molecules via (presumably membrane-coupled) LC3B. MHC class I surface stabilization on DCs lacking Atg8 lipidation is associated with enhanced CD8 + T cell responses during influenza A virus (IAV) and lymphocytic choriomeningitis virus (LCMV) infection, resulting in improved immune control of IAV. These findings establish a role for the macroautophagy machinery in controlling MHC class I expression and in shaping anti-viral CD8 + T cell responses.
RESULTS
Increased MHC Class I Levels on Autophagy-Deficient atg5 À/À or atg7 À/À DCs and Macrophages In Vitro and
In Vivo
In order to address whether MHC class I presentation could be affected by macroautophagy deficiency, we investigated mice in which atg5 or atg7 was conditionally deleted in DCs and CD11c-positive macrophages by crossing CD11c-cre mice with atg5-or atg7-floxed mice (atg5
Atg5 is a key component of the Atg8 E3-like ligase Atg5-Atg12-Atg16L1, required for autophagosome formation, and atg7 encodes the E1-like enzyme for both Atg8 and Atg12 conjugation. We analyzed the surface levels of the MHC class I molecules H2 Figures 1A and 1B) . Moreover, atg5-deficient bone-marrow-derived DCs (BM-DCs) displayed higher MHC class I levels than their wild-type counterparts ( Figure 1C ). In contrast, MHC class I surface expression was unchanged on B and T cells ( Figures 1D and S1D ). These data were confirmed in atg7 À/À DC mice. Although deletion efficiency seemed to be lower, resulting in residual LC3B lipidation in CD11c + cells of these mice (data not shown), MHC class I levels were elevated on Atg7-deficient macrophage and DC populations, but not B or T cells ( Figures 1E, S1E , and S1F). These findings suggest that deficiency in the core machinery of macroautophagy, which is required for Atg8 lipidation, increases MHC class I levels on myeloid antigen-presenting cells.
In order to address the mechanisms that could lead to MHC class I upregulation in the absence of macroautophagy, we tested four hypotheses. First, we ruled out a difference in MHC class I gene expression, by quantifying MHC class I transcript levels in flow cytometrically sorted splenic atg5 +/+ and atg5 À/À DCs ( Figure 2A ). No difference in MHC class I transcription was also confirmed in the investigated lung and splenic DC and macrophage subpopulations ( Figure 2B ). These data indicate that the increased MHC class I surface expression of macroautophagy-deficient DCs is not due to altered MHC class I gene transcription. We therefore addressed as the second hypothesis a difference in the availability of ubiquitinated substrates for proteasomal degradation and MHC class I loading. We could not detect any difference in the total amount of polyubiquitinated proteins in atg5 À/À DCs compared to atg5 +/+ DCs by western blot quantification (data not shown). As the third hypothesis, a faster assembly or transport to the cell surface of new MHC class I-peptide complexes was assessed in atg5 À/À DCs.
This could result from different mechanisms, as follows: a compensatory proteasomal ligand generation, an increased proteasomal activity in the absence of autophagic degradation of this multi-catalytic protease, or an enhanced vesicular transport to the cell surface (Dengjel et al., 2012; Marshall et al., 2015) . We did not see any difference in the rate of de novo expression of MHC class I molecules on the cell surface as assessed after acid stripping, which denatures surface MHC class I molecules, followed by measuring the kinetics of MHC class I recovery at the cell surface ( Figures 2C and 2D (Figures 3B and S1H) . Therefore, we concluded that a reduced internalization rate is responsible for higher surface expression of MHC class I molecules in atg5 À/À DCs and increased stability of MHC class I complexes on the cell surface.
In good agreement with these findings, the total amount of MHC class I molecules was nearly 2-fold higher in extracts of atg5
splenic DCs than in the respective atg5 +/+ controls as determined by immunoblot quantification ( Figures 3C and 3D ), suggesting enhanced degradation of MHC class I molecules after internalization in the presence of the macroautophagy core machinery. In order to determine if this loss of internalization in the absence of Atg5 also affected other surface receptors, we tested the expression of CD29, CD44, transferrin receptor (TfR), the co-stimulatory molecules CD80 and CD86, and MHC class II. Only CD80 seemed to be regulated in a similar fashion as MHC class I, as it showed a tendency toward stabilization on the cell surface of some atg5 À/À DC populations (mainly Figures 3G and 3H ). Treatment with the lysomotrophic agent chloroquine (CQ), elevating lysosomal pH and thereby inhibiting lysosomal hydrolases, accumulated MHC class I molecules in wild-type, but not in Atg5-deficient cells. In parallel LC3B-II also accumulated only in Atg5-positive DCs. Thus, the macroautophagy machinery assists in internalization and degradation of a subset of surface receptors, including MHC class I molecules, in DCs.
Atg Deficiency Compromises MHC Class I Association with AAK1, which Regulates MHC Class I Internalization
In order to analyze the molecular mechanism by which the macroautophagy machinery assists MHC I internalization and degradation, we immunoprecipitated MHC class I molecules from atg5 +/+ murine embryonic fibroblasts (MEFs) and analyzed the results by mass spectrometry. We found the following two molecules that were previously reported to be involved in receptor-mediated endocytosis and degradation (data not shown): the AAK1 (Conner and Schmid, 2002) and the Ral A binding protein 1 (RALBP1) (Nakashima et al., 1999) . First, we confirmed the mass spectrometry results by immunoprecipitation and western blot analysis. We were able to identify both AAK1 and RALBP1 in MHC class I immune precipitates of both atg5 À/À and atg5 +/+ BM-DCs (Figures 4A and S3A). However, only the association of AAK1 with MHC class I was significantly reduced in atg5 À/À BM-DCs, compared to their wild-type counterparts ( Figure 4A ). In good agreement, AAK1 association with MHC class I molecules was also reduced in Atg7-deficient BM-DCs ( Figure 4B ). RNA silencing of AAK1 stabilized MHC class I levels on both MEFs and BM-DCs ( Figures 4C, 4D , S3B, and S3C), confirming its previously published role during receptor internalization. Additionally, using the iLIR platform (Kalvari I et al., 2014 . Interestingly, the LIR sequences are conserved in the human AAK1 protein, but not in human RALBP1. We validated the interactions of LC3 with AAK1 and RALBP1 by co-immunoprecipitations. Indeed, we found that both AAK1 ( Figure 4E ) and RALBP1 ( Figure S3D ) could be co-immunoprecipiated with LC3B, but this association did not seem to be influenced by the macroautophagy core machinery. These data suggest that LC3 lipidation via the macroautophagy core machinery is required to efficiently localize AAK1 to MHC class I molecules for optimal internalization and degradation. DC mice ( Figures 6A and 6B ). In parallel, the specificity of the anti-viral CD8 + T cell responses was broader in atg5 À/À DC animals since at least two additional subdominant CD8 + T cell epitopes ) were recognized at frequencies reaching 10% of CD8 + T cells apart from the dominant NP1 366-374 epitope in the C57BL/6 mouse background. Accordingly, recognition of subdominant IAV epitopes reached levels of wild-type dominant epitope recognition in atg5 À/À DC mice. Furthermore, we found that elevated CD8 + T cell responses correlated with protection from IAV-induced disease. The infectious lung viral titers at day 8 were significantly reduced in atg5 À/À DC mice ( Figure 6C ). Additionally, a significant correlation between the magnitude of the anti-viral CD8 + T cell response and weight loss was observed ( Figure 6D ), indicating that the increased CD8 + T cell responses in the absence of the macroautophagy core machinery protected from morbidity during IAV infection. The specific anti-viral CD4 + T cell responses and the influenza-specific antibody titers were not significantly different in atg5 À/À DC animals compared to their wild-type littermates (atg5 +/+ DC) ( Figures S4B and S4C) . In good agreement, MHC class I surface expression remained elevated on Atg 5-deficient DCs and macrophages during IAV infection ( Figure S2E ), while with the exception of CD80 co-stimulatory molecules were unchanged ( Figure S2F ). Thus, while the protective CD8 
Cytokine Production and Early Viral Titers in IAV-Infected Mice with DCs that Lack Components of the Macroautophagy Machinery
In order to exclude that changes in early innate immune control and cytokines would allow IAV to replicate to higher viral titers resulting in elevated IAV-specific CD8 + T cell responses in atg5 À/À DC mice, we analyzed cytokine production and IAV titers on day 3 after infection. Cytokine secretion in response to infection was similar for interleukin-6 (IL-6) and interferon-g (IFN-g) in atg5
À/À DC mice ( Figures S5A and S5B ). IL-1b, however, was increased ( Figure S5C ), but these elevated IL-1b levels were not able to control IAV infection early on, as demonstrated by similar viral titers between wild-type and knockout mice on day 3 after infection ( Figure S5D ). Therefore, changes in innate immune control are unlikely to account for the elevated CD8 + T cell responses and improved immune control in atg5 À/À DC mice. that stabilized MHC class I levels on macroautophagy-machinery-deficient DCs contribute to elevated priming of anti-viral CD8 + T cell responses in vivo.
DISCUSSION
Our studies describe a role for lipidated LC3B in recruiting the internalization machinery to MHC class I molecules. In the absence of this recruitment, MHC class I gets stabilized on the surface of myeloid antigen-presenting cells. This results in elevated CD8 + T cell responses during IAV and LCMV infections. Therefore, the macroautophagy machinery seems to attenuate MHC class I restricted antigen presentation, while it was previously shown to enhance MHC class II restricted antigen presentation.
MHC class I internalization seems to utilize at least two pathways. Recycling of MHC class I molecules has been shown to follow an ADP-ribosylation factor 6 (ARF6)-dependent endocytosis pathway (Naslavsky et al., 2004) . This pathway is clathrin and dynamin independent. In contrast, AAK1, whose recruitment to MHC class I we found to be LC3B lipidation dependent, has been mainly implicated in clathrin-and dynamin-mediated endocytosis (Conner and Schmid, 2002; Henderson and Conner, 2007) . The latter pathway seems to lead to lysosomal degradation of MHC class I and is also targeted by the K3 and K5 ubiquitin E3 ligases of the Kaposi sarcoma-associated herpesvirus (KSHV) (Coscoy et al., 2001; Hewitt et al., 2002) . Interestingly, an ubiquitin mutant that affects this MHC class I internalization for degradation by K3 also affects MHC class I surface stability of cells that do not express these viral proteins (Duncan et al., 2010) , suggesting that possibly membrane-associated RING-CH (MARCH) E3-ubiquitin ligases engage the same pathway. Indeed, MARCH4 and MARCH9 overexpression has been shown to stimulate MHC class I internalization for degradation (Nathan and Lehner, 2009 ). Thus, AAK1 recruitment via LC3B lipidation seems to assist MHC class I internalization for degradation, possibly enhancing an ubiquitin, clathrin-and dynamin-dependent internalization pathway. Compromising this internalization pathway seemed to also deplete the recently described vesicular MHC class I pools (Nair-Gupta et al., 2014), which were described to supply MHC class I molecules for cross-presentation of TLR engaging antigens. Interestingly, the macroautophagy machinery has been previously suggested to support clathrin-dependent endocytosis. Components of the AP2 complex, which is also directly phosphorylated by AAK1, have been found to interact with lipidated LC3B for Alzheimer precursor protein internalization and degradation (Tian et al., 2013) . However, we did not find AP2 components significantly enriched in MHC class I immunoprecipitates (data not shown), and AAK1 can also support AP2-independent, but clathrindependent, endocytosis (Gupta-Rossi et al., 2011; Henderson and Conner, 2007) . Thus, LC3B lipidation seems to affect different clathrin-dependent internalization and degradation steps of surface receptors, including MHC class I endocytosis.
We found that Atg-dependent MHC class I stabilization is associated with elevated CD8 + T cell stimulation in vitro and in vivo. In addition, various contributions of the macroautophagy machinery to antigen processing for MHC class I presentation have been reported. While some studies found that Atg deficiency in antigen-presenting cells did not affect exogenous antigen cross-presentation to CD8 + T cells (Lee et al., 2010) , others have shown that the macroautophagy machinery enhances (Fiegl et al., 2013; Mintern et al., 2015) or inhibits (Baghdadi et al., 2013; Hubbard-Lucey et al., 2014) cross-presentation. Moreover, it has been suggested that the macroautophagy machinery supports packaging of antigens in antigen donor cells for efficient cross-presentation (Li et al., 2008; Uhl et al., 2009) . With respect to endogenous antigens, targeting of antigens to autophagosomes via fusion constructs with LC3B did not significantly enhance MHC class I presentation , and macroautophagy seems to even restrict MHC class I antigen presentation of defective ribosomal products (Wenger et al., 2012) . However, under conditions of inhibition of the classical MHC class I antigen processing pathway late in herpesvirus infections, it was reported that macroautophagy can deliver antigens for MHC class I presentation (English et al., 2009; Tey and Khanna, 2012) . While most of these studies investigated the loss of components in the macroautophagy machinery in vitro, we and others have noted hyper-reactivity of CD8 + T cell responses in the absence of Atgs in antigen-presenting cells (Hubbard-Lucey et al., 2014) and in colorectal tumor cells (Lé vy et al., 2015) , and we demonstrate in this study that MHC class I stabilization on DCs is associated with elevated anti-viral CD8 + T cell responses in vivo. Nevertheless, we cannot exclude that in addition to MHC class I stabilization additional factors contribute to the increased CD8 + T cell responses to viral infections in mice with Atg deficiency in DCs. Along these lines both the elevated CD80 surface expression on at least some subsets of DCs and the increased IL-1b production early during IAV infection could contribute. Our study sheds light on the molecular mechanism of MHC class I internalization and degradation, involving recruitment of the internalization factor AAK1 via LC3B lipidation in this process. Thus, Atgs seem to balance MHC class I and II antigen presentation, being beneficial for CD4 + T cell stimulation and restricting CD8 + T cell responses at the same time. A comprehensive understanding of how the macroautophagy machinery interferes with MHC restricted antigen presentation seems required to predict the outcome of therapeutic interventions in this pathway to boost adaptive immunity.
EXPERIMENTAL PROCEDURES
Animals 8-to 12-week-old C57BL/6 (Janvier), atg5 flox/flox (Hara et al., 2006) , atg7 flox/flox (Komatsu et al., 2005) , and CD11c-Cre Tg (Jackson ImmunoResearch Laboratories) were bred in the UZH animal facility. All procedures used in the study complied with Swiss federal law for animal experimental procedures. All animal protocols were approved by the cantonal veterinary offices of the cantons of Z€ urich or of Geneva, Switzerland (protocol No. 117/2008 , 134/2011 , Medecine FRM 1005 , and ZH210/2014 .
Influenza Virus Infection In Vivo
Influenza A/PR8 virus (H1N1) virus was used for all experiments and purchased from Charles River. Mice were anesthetized and infected intra-nasally by the application of 25 ml of virus suspension (doses of virus were chosen between 0.1 and 10 HA units depending on the experiment). 
Influenza Virus Infection In Vitro

Primary Antibodies for Immunoblot Detection
The following primary antibodies were used: rabbit anti H2-K b (Exon-8) (a gift from Dr. Jack Bennink, Bethesda, MD), anti-actin-HRP (Sigma-Aldrich), mouse anti-Atg5 (Nanotools), rabbit anti-LC3 (MBL International), mouse anti-LC3 (clone 5F10-Nanotools), rabbit anti-AAK1 (Abcam), and rabbit anti-RALBP1 (EMELCA).
Secondary Antibodies for Immunoblot Detection
The clean blot-HRP antibody (Life Technologies) and a goat-anti-mouse HRP (Bio-Rad) were used.
Peptides, Chemicals, and Inhibitors
Peptides were synthesized by GL Biochem at a purity > 90%. Carboxyfluorescein succinimidyl ester (CFSE) was used at 0.5 mM and was from Molecular Probes.
Flow Cytometry
Cells were acquired on a FACSFortessa flow cytometer using FACSDiva Version 6.1.3 software (BD Biosciences) or a FACSCanto II (BD Biosciences), and all flow cytometry analyses were performed with FlowJo Version 9.3.1 software (Treestar).
Influenza-Virus-Specific T Cell Proliferation
Influenza-specific polyclonal T cells were expanded from splenocytes of wildtype mice at day 12/14 post influenza infection, as previously described (Longhi et al., 2009) , and cultured for 6/7 days in RPMI supplemented with 10% FCS and 40 units/ml of IL-2. For DC/T cell co-cultures, atg5 +/+ and atg5 À/À splenic DC were influenza infected in vitro at a MOI of 200 and seeded overnight in R5 supplemented with GM-CSF or pulsed with 0.1 or 1 mM NP1 366-374 peptide for 1 hr. DCs were then co-cultured in 96 flat-bottom plates, at a 1/1 ratio with CFSE-labeled IAV-specific T cells (obtained from polyclonal T cell lines, or from lungs of wild-type infected animals). Co-culture with non-infected DCs was used as a control. Where indicated, CD80-specific blocking antibodies were added (10 mg/ml of clone 16-10A1) during the DC coculture with T cells.
Intracellular IFN-g Staining
Lung single-cell suspensions obtained after Percoll gradient centrifugation were incubated in R10 at 37 C for 5 hr in the presence of CD28-(2 mg/ml) and influenza-specific peptides (10 mg/ml). Brefeldin A (10 mg/ml) was added after the first hour. Extracellular staining was performed (CD4, CD8, and live/ dead Aqua). Then cells were fixed and permeabilized using a BD Cytofix Cytoperm Fixation/Permeabilization Kit and stained for IFN-g.
ELISA Assay
For detection of cytokines in the lungs, lungs were weighted and resuspended in PBS (0.4 mg in 1.5 ml), then disrupted mechanically, using a Polytron.
Homogenates were then centrifuged at 13,000 RPM for 30 min, and supernatants were tested for cytokine detection. Mouse Il-6 and IFN-g ELISA kits were purchased from BioLegend. The mouse IL-1b ELISA kit was purchased from eBioscience or R&D. 
MHC Class I Assays
Immunoprecipitation
Lysates from BM-DCs were used at day 10 post differentiation. Cells were lysed in a 50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% NP-40 buffer supplemented with protease inhibitors (Roche). Equal protein amounts from atg5 À/À and atg5 +/+ lysates were used after bicinchoninic acid assay quantification.
A minimum input of 1 mg was used per condition. Following a pre-clearing step of 1 hr, lysates were immunoprecipitated overnight at 4 C using either anti-MHC class I (exon8) or anti-LC3 (MBL International) antibodies. In parallel a rabbit control serum was used as a negative control. The next day cell lysates were further incubated with protein A beads (Pierce) for 2 hr. After five washes, beads were denaturated in SDS page loading buffer and co-immunoprecipitated proteins were analyzed by western blot. Immunoblot quantification was done using the Image J software.
Immune Fluorescence Microscopy
CD11c-positive cells were cultured overnight at 37 C in complete RPMI on coverslips. The next day, cells were washed in PBS three times and incubated with Fc blocker 2.4G2 Fcc III/II (BD Pharmingen) for 30 min at 4 C, followed by labeling for H2-K b (antibody AF6-88.5) or H2 class I (antibody M1/42) for 30 min at 4 C. Next, they were incubated at 37 C for 1 hr, washed with PBS, and fixed in 4% paraformaldehyde 20 min at room temperature. Cells were washed with PBS, permeabilized with 0.1% Triton X-100, and saturated with 1% BSA for 1 hr. Binding of the primary antibody was detected with Alexa Fluor 555 goat anti-rat IgG H&L, and cell nuclei were stained with DAPI. Fluorescence was analyzed with a confocal laser scanning microscope.
Statistical Analysis Statistical significance was tested by Student's t test with PRISM software (Version 5; GraphPad software). p values of less than 0.05 were considered statistically significant. 
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